Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine

Summary Company Announcement Date: July 18, 2026 FDA Publish Date: July 20, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential cross contamination with Ranitidine Company Name: Unique Pharmaceutical Laboratories Brand Name: Brand...